A new weight loss pill, currently in testing within the NHS in the UK, could become a revolutionary alternative to weight loss methods, including Ozempic.
Named Sirona, this capsule contains a blend of gels that, once ingested in the morning with a glass of water, expands in the stomach in just 30 minutes, quickly providing a feeling of fullness, as reported by Daily Mail.
The expandable gel is not absorbed by the body but breaks down in the stomach and is naturally eliminated through feces.
In a 12-week clinical study, patients taking Sirona lost an average of 3.6 kilograms, with some even losing up to 10% of their body weight, results comparable or better than those obtained with semaglutide-based injections (Ozempic) or tirzepatide (Mounjaro). However, common side effects such as nausea, abdominal pain, and others were absent.
One study participant reduced their body mass index from 37.7 to 31.2 in just three months.
Dr. Asif Humayun, an NHS endocrinologist, stated that Sirona represents a "new generation of obesity treatments." Additionally, this treatment can fill the gap left by injections, being intended for overweight individuals as well as obese ones, as explained by Dr. Camilla Easter, CEO of Oxford Medical Products.
In the future, studies on the new medication will be expanded both in the UK and the US, with the goal of Sirona being widely used as a complementary aid in diets and healthy lifestyles.
Unlike GLP-1 injections, for example, which can cause severe reactions and risks upon treatment discontinuation (such as rapid weight regain), Sirona could help maintain weight in the long term, without associated side effects.